ADVANCED OPTIONS FOR MANAGING YOUR DIABETIC NEUROPATHY
Not finding relief from diabetic neuropathy? Talk to us about advanced care.
Painful Diabetic Neuropathy (PDN): A Chronic, Debilitating Pain with Limited Treatment Options
Diabetic peripheral neuropathy is a form of nerve damage caused by high blood sugar that affects nearly half of all adults with diabetes. For millions of people, this condition leads to chronic pain, numbness, and disrupted sleep, while significantly increasing the risk of serious complications like falls, infections, and ulcers.
Current Treatments Leave Room for Improvement
Unfortunately, traditional management strategies—including physical therapy, injections, and standard medications—frequently fail to provide long-term relief, and options like opioids carry risks of dependency without truly improving daily functionality or quality of life.
Advanced Treatment Options for Diabetic Neuropathy
HFX™
High-Frequency Nerve Pain Relief
Nevro HFX is an FDA-approved spinal cord stimulation therapy using high-frequency pulses to calm nerve pain without a tingling sensation. It reduces shooting, burning, and “pins and needles” discomfort, improves sleep, and can even help restore physical feeling in the feet.
Proclaim™ DRG Therapy
Targeted Relief for Foot & Leg Pain
Proclaim™ DRG Therapy precisely targets the dorsal root ganglion—the nerve cluster managing lower extremity pain. By intercepting pain signals right at the source, this recharge-free implant provides deep, localized relief in the feet and legs without full-body stimulation.
Axon mPNS
Non-Invasive Magnetic Pain Relief
Axon mPNS offers a 100% non-invasive, drug-free approach to diabetic nerve pain with no surgery or implants. Delivered via quick, painless magnetic pulses through the skin during brief office visits, it resets hyperactive nerve pathways to relieve chronic burning and tingling.
Spinal Cord Stimulation
Implantable Spinal Stimulation
Spinal Cord Stimulation (SCS) is a proven, non-opioid implantable therapy. Delivering mild electrical currents near the spine via a minimally invasive procedure, it disrupts pain signals and replaces raw burning or shooting pain with a gentle tingling.
Qutenza
Targeted Topical Patch Relief
Qutenza is an FDA-approved 8% capsaicin topical patch applied during a brief office visit. It works directly at the skin level to desensitize hyperactive pain receptors in the feet, providing up to three months of localized relief without the systemic side effects of oral drugs.
Request An Appointment
Please feel free to contact our friendly reception staff with any general or medical inquiry
DOUBLE BOARD-CERTIFIED
Dr. David J. Arcella
Dr. David J. Arcella is a Harvard trained Interventional Pain Management Specialist. He has contributed to research in opioid alternative medications and medication-free pain management options, as well as surgical anesthesia techniques to minimize the incidence of chronic pain. Dr. Arcella believes in creating a collaborative care plan with his patients and customizing treatments to each patient’s individual goals.
Testimonials
ACCEPTED
Insurances
ACCEPTED
Insurances
References:
- CDC 2020 National Diabetes Statistics Report.
- Hicks CW, Selvin E. Curr Diab Rep. 2019;19(10):86
- CDC National Diabetes Statistics Report 2020; Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18(6):350-354; Trinity Partners Market Research 2017
- Petersen, E, et. al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. JAMA Neurology, April 2021.
References:
- CDC 2020 National Diabetes Statistics Report.
- Hicks CW, Selvin E. Curr Diab Rep. 2019;19(10):86
- CDC National Diabetes Statistics Report 2020; Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18(6):350-354; Trinity Partners Market Research 2017
- Petersen, E, et. al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. JAMA Neurology, April 2021.